Oshita F - Search Results

1

Multiplex genomic test of mutation and fusion genes in small biopsy specimen of lung cancer.

Oshita F, Kasajima R, Miyagi Y. Oshita F, et al. J Exp Ther Oncol. 2016 Jul;11(3):189-194. J Exp Ther Oncol. 2016. PMID: 28471124

2

Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by promoter methylation and silencing of the retinoic acid receptor-beta.

Oshita F, Sekiyama A, Suzuki R, Ikehara M, Yamada K, Saito H, Noda K, Miyagi Y. Oshita F, et al. Oncol Rep. 2003 Jan-Feb;10(1):105-8. Oncol Rep. 2003. PMID: 12469153

3

Genome-wide cDNA microarray screening to correlate gene expression profile with survival in patients with advanced lung cancer.

Ikehara M, Oshita F, Sekiyama A, Hamanaka N, Saito H, Yamada K, Noda K, Kameda Y, Miyagi Y. Ikehara M, et al. Among authors: oshita f. Oncol Rep. 2004 May;11(5):1041-4. Oncol Rep. 2004. PMID: 15069544

4

Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.

Oshita F, Ikehara M, Sekiyama A, Hamanaka N, Saito H, Yamada K, Noda K, Kameda Y, Miyagi Y. Oshita F, et al. J Exp Ther Oncol. 2004 Jul;4(2):155-60. J Exp Ther Oncol. 2004. PMID: 15500010

5

Genome-wide cDNA microarray screening of genes related to survival in patients after curative resection of non-small cell lung cancer.

Oshita F, Sekiyama A, Ito H, Kameda Y, Miyagi Y. Oshita F, et al. Oncol Rep. 2006 Oct;16(4):817-21. Oncol Rep. 2006. PMID: 16969500

6

Genome-wide cDNA microarray screening of genes related to the benefits of paclitaxel and irinotecan chemotherapy in patients with advanced non-small cell lung cancer.

Oshita F, Sekiyama A, Saito H, Yamada K, Noda K, Miyagi Y. Oshita F, et al. J Exp Ther Oncol. 2006;6(1):49-53. J Exp Ther Oncol. 2006. PMID: 17228524

7

Proteomic screening of completely resected tumors in relation to survival in patients with stage I non-small cell lung cancer.

Oshita F, Morita A, Ito H, Kameda Y, Tsuchiya E, Asai S, Miyagi Y. Oshita F, et al. Oncol Rep. 2010 Sep;24(3):637-45. doi: 10.3892/or_00000902. Oncol Rep. 2010. PMID: 20664968

8

Prospective study of second-line chemotherapy for non-small cell lung cancer selected according to EGFR gene status.

Oshita F, Miyagi Y, Honda T, Murakami S, Kondo T, Saito H, Noda K, Yokose T, Kameda Y, Sakuma Y, Obata M, Yamada K. Oshita F, et al. J Exp Ther Oncol. 2010;8(4):313-9. J Exp Ther Oncol. 2010. PMID: 21222363

9

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non-small-cell lung cancer.

Nishii T, Yokose T, Miyagi Y, Daigo Y, Ito H, Isaka T, Imai K, Murakami S, Kondo T, Saito H, Oshita F, Yamada K, Matsukuma S, Tsuboi M, Nakayama H, Masuda M. Nishii T, et al. Among authors: oshita f. BMC Cancer. 2014 Aug 25;14:610. doi: 10.1186/1471-2407-14-610. BMC Cancer. 2014. PMID: 25152277 Free PMC article.

10

Genomewide cDNA microarray screening of genes related to benefits and toxicities of platinum-based chemotherapy in patients with advanced lung cancer.

Oshita F, Ikehara M, Sekiyama A, Hamanaka N, Saito H, Yamada K, Noda K, Kameda Y, Miyagi Y. Oshita F, et al. Am J Clin Oncol. 2005 Aug;28(4):367-70. doi: 10.1097/01.coc.0000158828.06866.ec. Am J Clin Oncol. 2005. PMID: 16062078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters